Ross D LeClaire

Title: Ross D. LeClaire: Innovator in Ricin Vaccine Development

Introduction

Ross D. LeClaire is a notable inventor based in Frederick, MD (US). He has made significant contributions to the field of immunology, particularly in the development of vaccines against ricin intoxication. His work is crucial in addressing bioterrorism threats and enhancing public health safety.

Latest Patents

LeClaire holds a patent for a ricin vaccine and methods of making and using it. The patent discloses polypeptides and variants that comprise a sequence having substantial identity to ricin A chain (RTA). These polypeptides lack detectable N-glycosidase-rRNA activity or exhibit reduced activity compared to controls. They also demonstrate greater solubility in aqueous solutions of physiological pH and ionic strength than RTA while retaining the integrity of the neutralizing immunological epitope of wild type RTA. Additionally, the patent outlines immunogenic compositions that can be used to immunize subjects against ricin intoxication, along with methods for immunizing, treating, and preventing ricin intoxication.

Career Highlights

LeClaire is currently employed by the US Government as represented by the Secretary of the Army. His role involves research and development aimed at enhancing national security through innovative medical solutions. His expertise in immunology and vaccine development has positioned him as a key figure in his field.

Collaborations

LeClaire has collaborated with notable colleagues, including Robert W. Wannemacher and Michael P. Byrne. These partnerships have contributed to the advancement of research in vaccine development and public health safety.

Conclusion

Ross D. LeClaire's work in developing a ricin vaccine exemplifies the importance of innovation in addressing public health challenges. His contributions are vital in the ongoing efforts to protect against bioterrorism and enhance immunological defenses.